Literature DB >> 8343735

Insulin resistance in offspring of hypertensive parents.

O L Beatty1, R Harper, B Sheridan, A B Atkinson, P M Bell.   

Abstract

OBJECTIVE: To determine if insulin resistance is present in normotensive adults at increased risk of developing hypertension.
DESIGN: Normotensive subjects with at least one hypertensive parent were paired with offspring of normotensive parents (controls), being matched for age, sex, social class, and physical activity.
SETTING: Outpatient clinic.
SUBJECTS: 30 paired subjects (16 men and 14 women) with and without a family history of hypertension, aged 18-32, with a body mass index < 25 kg/m2, with blood pressure < 130/85 mm Hg, and not taking drugs.
INTERVENTIONS: Euglycaemic glucose clamp (two hour infusion of insulin 1 mU/kg/min) and intravenous glucose tolerance test (injection of 100 ml 20% glucose). MAIN OUTCOME MEASURES: Insulin mediated glucose disposal and insulin secretion.
RESULTS: The offspring of hypertensive parents had slightly higher blood pressure than did the controls (mean 117 (SD 6) v 108 (5) mm Hg systolic, p = 0.013; 76 (7) v 67 (6) mm Hg diastolic, p = 0.017). Their insulin mediated glucose disposal was lower than that of controls (29.5 (6.5) v 40.1 (8.6) mumol/kg/min, p = 0.002), but, after adjustment for blood pressure, the difference was not significant (difference 6.9 (95% confidence interval -1.5 to 15.3), p = 0.10). Insulin secretion in the first hour after injection of glucose was slightly but not significantly higher in the offspring of hypertensive patients (9320 (5484) v 6723 (3751) pmol.min/l). The two groups had similar concentrations of plasma glucose (5.2 (0.3) v 5.1 (0.4) mmol/l), serum cholesterol (4.4 (0.8) v 4.6 (0.8) mmol/l), serum triglyceride (0.89 (0.52) v 0.68 (0.27) mmol/l), and serum low density lipoprotein cholesterol (2.81 (0.65) v 2.79 (0.61) mmol/l). The offspring of hypertensive parents, however, had lower serum concentrations of high density lipoprotein cholesterol (1.24 (0.31) v 1.56 (0.35) mmol/l, p = 0.002) and higher serum concentrations of non-esterified fatty acids (0.7 (0.4) v 0.4 (0.4) mmol/l, p = 0.039).
CONCLUSIONS: Young normotensive subjects who are at increased risk of developing hypertension are insulin resistant.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8343735      PMCID: PMC1693494          DOI: 10.1136/bmj.307.6896.92

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  38 in total

1.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.

Authors:  P J RANDLE; P B GARLAND; C N HALES; E A NEWSHOLME
Journal:  Lancet       Date:  1963-04-13       Impact factor: 79.321

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  Study of the relationship between glucose and insulin responses to an oral glucose load in man.

Authors:  G Reaven; R Miller
Journal:  Diabetes       Date:  1968-09       Impact factor: 9.461

Review 4.  Effects of insulin upon ion transport.

Authors:  R D Moore
Journal:  Biochim Biophys Acta       Date:  1983-03-21

5.  Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man.

Authors:  J W Rowe; J B Young; K L Minaker; A L Stevens; J Pallotta; L Landsberg
Journal:  Diabetes       Date:  1981-03       Impact factor: 9.461

Review 6.  The effect of insulin on renal sodium metabolism. A review with clinical implications.

Authors:  R A DeFronzo
Journal:  Diabetologia       Date:  1981-09       Impact factor: 10.122

7.  Family (parental) history and prevalence of hypertension. Results of a nationwide screening program.

Authors:  R Stamler; J Stamler; W F Riedlinger; G Algera; R H Roberts
Journal:  JAMA       Date:  1979-01-05       Impact factor: 56.272

8.  Insulin secretion, insulin resistance, and obesity.

Authors:  R A DeFronzo
Journal:  Int J Obes       Date:  1982

9.  Mechanism and significance of insulin resistance in non-insulin-dependent diabetes mellitus.

Authors:  R A Rizza; L J Mandarino; J E Gerich
Journal:  Diabetes       Date:  1981-12       Impact factor: 9.461

10.  Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.

Authors:  O G Kolterman; J Insel; M Saekow; J M Olefsky
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

View more
  10 in total

Review 1.  Insulin resistance.

Authors:  A J Krentz
Journal:  BMJ       Date:  1996-11-30

2.  The antihypertensive effect of arginine.

Authors:  Sudesh Vasdev; Vicki Gill
Journal:  Int J Angiol       Date:  2008

3.  The antihypertensive effect of cysteine.

Authors:  Sudesh Vasdev; Pawan Singal; Vicki Gill
Journal:  Int J Angiol       Date:  2009

Review 4.  Effects of exercise training on abdominal obesity and related metabolic complications.

Authors:  B Buemann; A Tremblay
Journal:  Sports Med       Date:  1996-03       Impact factor: 11.136

5.  Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial.

Authors:  Jonathan Q Purnell; Raj K Dev; Michael W Steffes; Patricia A Cleary; Jerry P Palmer; Irl B Hirsch; John E Hokanson; John D Brunzell
Journal:  Diabetes       Date:  2003-10       Impact factor: 9.461

Review 6.  Nutrition, hormones, and breast cancer: is insulin the missing link?

Authors:  R Kaaks
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

7.  Insulin resistance in relatives of NIDDM patients: the role of physical fitness and muscle metabolism.

Authors:  B Nyholm; A Mengel; S Nielsen; C Skjaerbaek; N Møller; K G Alberti; O Schmitz
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

Review 8.  Prevention of type 2 diabetes.

Authors:  Samy I McFarlane; John J Shin; Tanja Rundek; J Thomas Bigger
Journal:  Curr Diab Rep       Date:  2003-06       Impact factor: 4.810

Review 9.  Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management.

Authors:  Fadi El-Atat; Samy I McFarlane; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2004-06       Impact factor: 5.369

10.  Apelin and relaxin plasma levels in young healthy offspring of patients with essential hypertension.

Authors:  Dimitris P Papadopoulos; Thomas Makris; Despina Perrea; Kannelina Zerva; Costas Tsioufis; Charles Faselis; Vasilios Papademetriou
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-02-20       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.